“The drug performs quite well in mice and the authors hint at it having potential against other viruses too,” said David H. O’Connor, a professor of pathology and laboratory medicine at the University of Wisconsin-Madison. “It is premature to say if it will have clinical benefit, but it definitely merits clinical trials.”